1. Home
  2. VRAR vs ITRM Comparison

VRAR vs ITRM Comparison

Compare VRAR & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$0.94

Market Cap

21.9M

Sector

Technology

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.41

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
ITRM
Founded
2016
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
24.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
VRAR
ITRM
Price
$0.94
$0.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.62
$9.00
AVG Volume (30 Days)
105.4K
1.0M
Earning Date
11-13-2025
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
16.60
N/A
52 Week Low
$0.89
$0.36
52 Week High
$7.00
$2.10

Technical Indicators

Market Signals
Indicator
VRAR
ITRM
Relative Strength Index (RSI) 32.01 36.53
Support Level $1.03 $0.44
Resistance Level $1.16 $0.49
Average True Range (ATR) 0.09 0.04
MACD -0.00 0.01
Stochastic Oscillator 2.52 1.35

Price Performance

Historical Comparison
VRAR
ITRM

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: